Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
The current price of Johnson & Johnson in the market is 946,86 zł, with a 24-hour trading volume of 8,23B zł. The asset's market cap is 2,27T zł, after moving 0.26% in the last day.
Tokenized Johnson & Johnson is trading at 954,44 zł, with a tokenized market cap of 156,52M zł and a 24-hour trading volume of 3,49M zł. The tokenized asset has moved -0.62% in the past 24 hours.